DE2265399C2 - Antioxidativ und/oder tumorhemmend wirksames Mittel - Google Patents

Antioxidativ und/oder tumorhemmend wirksames Mittel

Info

Publication number
DE2265399C2
DE2265399C2 DE2265399A DE2265399A DE2265399C2 DE 2265399 C2 DE2265399 C2 DE 2265399C2 DE 2265399 A DE2265399 A DE 2265399A DE 2265399 A DE2265399 A DE 2265399A DE 2265399 C2 DE2265399 C2 DE 2265399C2
Authority
DE
Germany
Prior art keywords
methane
trimethyl
mixture
formaldehyde
trlmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2265399A
Other languages
German (de)
English (en)
Inventor
Vilmos Dipl.-Chem.-Ing. Bär
Jenö Dipl.-Chem.-Ing. Mercz
Jakab Dipl.-Agr.-Ing. Budapest Mátyás
Zsuzsa B. Dr. Pollák
János Dipl.-Chem.-Ing. Szvoboda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATERIAL VEGYI KSZ BUDAPEST HU
Original Assignee
MATERIAL VEGYI KSZ BUDAPEST HU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MATERIAL VEGYI KSZ BUDAPEST HU filed Critical MATERIAL VEGYI KSZ BUDAPEST HU
Application granted granted Critical
Publication of DE2265399C2 publication Critical patent/DE2265399C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3544—Organic compounds containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0042—Preserving by using additives, e.g. anti-oxidants containing nitrogen
    • C11B5/0064—Heterocyclic compounds containing nitrogen in the ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE2265399A 1971-09-07 1972-09-06 Antioxidativ und/oder tumorhemmend wirksames Mittel Expired DE2265399C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUBA2642A HU162358B (fr) 1971-09-07 1971-09-07

Publications (1)

Publication Number Publication Date
DE2265399C2 true DE2265399C2 (de) 1984-10-04

Family

ID=10993333

Family Applications (3)

Application Number Title Priority Date Filing Date
DE2243777A Expired DE2243777C3 (de) 1971-09-07 1972-09-06 Verwendung von Bis-(2,2,4-Trimethyl-1,2-dihydrochinol-6-yl)-methan bei der strahlensensibilisierenden Tumorhemmung
DE2265400A Expired DE2265400C2 (de) 1971-09-07 1972-09-06 1,1-[Bis-(2',2',4'-Trimethyl-1',2'-dihydrochinol-6'-yl)]-äthan und seine Säureadditionssalze, Verfahren zur Herstellung derselben und ihre Verwendung als Antioxydationsmittel
DE2265399A Expired DE2265399C2 (de) 1971-09-07 1972-09-06 Antioxidativ und/oder tumorhemmend wirksames Mittel

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE2243777A Expired DE2243777C3 (de) 1971-09-07 1972-09-06 Verwendung von Bis-(2,2,4-Trimethyl-1,2-dihydrochinol-6-yl)-methan bei der strahlensensibilisierenden Tumorhemmung
DE2265400A Expired DE2265400C2 (de) 1971-09-07 1972-09-06 1,1-[Bis-(2',2',4'-Trimethyl-1',2'-dihydrochinol-6'-yl)]-äthan und seine Säureadditionssalze, Verfahren zur Herstellung derselben und ihre Verwendung als Antioxydationsmittel

Country Status (22)

Country Link
JP (2) JPS5346839B2 (fr)
AT (1) AT319250B (fr)
AU (1) AU472125B2 (fr)
BE (1) BE788509A (fr)
BG (1) BG19596A3 (fr)
CA (1) CA992546A (fr)
CH (1) CH580079A5 (fr)
CS (1) CS170505B2 (fr)
DD (1) DD101667A5 (fr)
DE (3) DE2243777C3 (fr)
DK (1) DK135990B (fr)
ES (2) ES406433A1 (fr)
FR (1) FR2154469B1 (fr)
GB (1) GB1390991A (fr)
HU (1) HU162358B (fr)
IT (1) IT1022011B (fr)
NL (1) NL174721C (fr)
RO (1) RO60121A2 (fr)
SE (2) SE393982B (fr)
SU (1) SU520045A3 (fr)
YU (1) YU225772A (fr)
ZA (1) ZA725777B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185208B (en) * 1979-07-06 1984-12-28 Material Vegyipari Sz Process for producing the water-soluble derivatives of 6,6-methylene-bis/2,2,4-trimetyl-1,2-dihidric quinoline/
DK328483D0 (da) * 1983-07-15 1983-07-15 Magius N W Von Ethoxyquinsalte
HU194734B (en) * 1985-07-11 1988-03-28 Jozsef Bara Process for production of medical and applicable for human consumption products suitable for treatment and/or prevention of diseases caused by free-radical reactions
HU200165B (en) * 1987-04-22 1990-04-28 Material Vegyipari Szoevetkeze Process for producing dihydroquinoline derivatives, as well as pharmaceutical compositions, fodders and fodder premixes comprising such compounds
US5202338A (en) * 1990-10-31 1993-04-13 Vilmos Bar Dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihydroquinoline derivatives as modulators of the arachidonic acid cascade
EP0497735A1 (fr) * 1991-01-31 1992-08-05 Ciba-Geigy Ag Composés d'hydroquinoléine
CN116239529B (zh) * 2023-03-21 2024-05-24 山西大学 一种二氧化碳参与的n-甲基四氢喹啉类生物碱的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1906942A (en) * 1931-09-24 1933-05-02 Naugatuck Chem Co Treatment of rubber

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Also Published As

Publication number Publication date
DE2243777A1 (de) 1973-03-22
ES435497A1 (es) 1977-04-16
DD101667A5 (fr) 1973-11-12
DK135990C (fr) 1977-12-27
SE434050B (sv) 1984-07-02
GB1390991A (en) 1975-04-16
BG19596A3 (fr) 1975-06-25
JPS5940179B2 (ja) 1984-09-28
BE788509A (fr) 1973-01-02
SE393982B (sv) 1977-05-31
RO60121A2 (fr) 1976-09-20
JPS4861483A (fr) 1973-08-28
HU162358B (fr) 1973-02-28
DE2243777C3 (de) 1979-01-04
DK135990B (da) 1977-07-25
NL174721B (nl) 1984-03-01
AU4629872A (en) 1974-03-14
FR2154469A1 (fr) 1973-05-11
AT319250B (de) 1974-12-10
ZA725777B (en) 1973-09-26
SE7503840L (fr) 1975-04-03
JPS5346839B2 (fr) 1978-12-16
SU520045A3 (ru) 1976-06-30
AU472125B2 (en) 1976-05-20
ES406433A1 (es) 1976-01-16
NL7212192A (fr) 1973-03-09
YU225772A (en) 1982-02-28
IT1022011B (it) 1978-03-20
NL174721C (nl) 1984-08-01
JPS5467576A (en) 1979-05-31
DE2243777B2 (de) 1978-05-03
CH580079A5 (fr) 1976-09-30
CS170505B2 (fr) 1976-08-27
FR2154469B1 (fr) 1976-03-05
DE2265400C2 (de) 1982-04-08
CA992546A (en) 1976-07-06

Similar Documents

Publication Publication Date Title
DE10196213B4 (de) Verwendung von Tetrahydropiperin zur Erhöhung der Bioverfügbarkeit von Nährstoffen und pharmazeutischen Präparationen
DE3152175C2 (fr)
DE2440436C3 (de) Arzneimittel für die Behandlung sekretorischer Beschwerden der Prostata
DE2265399C2 (de) Antioxidativ und/oder tumorhemmend wirksames Mittel
DE69917796T2 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
DE60033383T2 (de) Verwendung von tetrahydrocurcuminoiden zur regulation von physiologischen und pathologischen fällen in der haut und mucosa
DE2642879C3 (de) 4-Aroyl-2,3-Dichlorphenoxyessigsäuren und diese enthaltende Arzneimittel
DE2625012B2 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE60103867T2 (de) Spezielle Salzformen von Triphenylethylenderivaten als selektive Östrogenrezeptor-Modulatoren
DE2349538C2 (de) Arzneimittel zur Behandlung von Lebererkrankungen
DE1668385C3 (de) Quaternare Semicarbazon und Thiosemicarbazon Salze, Verfahren zu deren Herstellung und diese enthalten de pharmazeutische Zusammensetzungen
DE2625220C3 (de) Arzneimittel zur Behandlung von Leberkrankheiten
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE3025656C2 (fr)
DD141023A5 (de) Verfahren zur herstellung eines 2,3-dihydrobenzofuranderivats
DE2623486A1 (de) 3.5.5-trimethylhexanoyl-ferrocen und verfahren zu seiner herstellung
EP0212137B1 (fr) Utilisation d'un rétinoide pour l'obtention d'un médicament cytostatique.
DE2038836C3 (de) Arzneimittel
CH652929A5 (de) Pharmazeutisches praeparat zur regulierung der konzentration an calcium im serum von menschen und warmbluetigen tieren und peroxylactone.
DE2501649C3 (de) Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2336176A1 (de) Nahrungs- und futtermittelzusatz und verfahren zu seiner herstellung
DE2704744C2 (de) Fettsäureamide von α-Methyl-m-(trifluormethyl)-phenäthylamin, Verfahren zu ihrer Herstellung und Arzneimittel
DE2362813C3 (de) Sbeta-Cycloalkyloxy-iealpha-cyan-pregn-Sen-20-one, Verfahren zu deren Herstellung sowie diese enthaltende Mittel Syntex (U.S.A.) Inc., Palo Alto, Calif. (V.St.A.)
DE2145686C3 (de) 2-Chlor-S-sulfamylbenzoesäurederivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE2713506A1 (de) Ester der 2- eckige klammer auf 4-(4-chlorbenzoyl)-phenoxy eckige klammer zu -2-methylpropionsaeure mit bis-(hydroxyalkylthio)-alkanen und sie enthaltende arzneimittel

Legal Events

Date Code Title Description
OD Request for examination
OD Request for examination
AC Divided out of

Ref country code: DE

Ref document number: 2243777

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition